Related Experiment Video
Updated: Aug 9, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Urinary Dickkopf-3 as a biomarker for kidney-function decline: a systematic review and meta-analysis
Yiwei Shang1,2, Binqi Wang1,2, Yue Huang1,2
1Department of Nephrology, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang, P.R. China.
Higher urinary Dickkopf-3 (uDKK3) indicates kidney function decline and fibrosis. This tubular-stress biomarker shows promise for risk stratification in kidney disease, complementing existing measures like eGFR.
Area of Science:
- Nephrology
- Biomarker Discovery
- Tubulointerstitial Disease
Background:
- Urinary Dickkopf-3 (uDKK3) is a glycoprotein linked to tubular injury, Wnt signaling, and kidney remodeling.
- Human studies on uDKK3 involve chronic kidney disease (CKD), cardiorenal disease, and transplantation.
- Existing research shows variability in clinical endpoints and assay platforms for uDKK3.
Purpose of the Study:
- To systematically review and synthesize human studies on urinary Dickkopf-3 (uDKK3).
- To assess the association of uDKK3 with kidney function decline, kidney failure, fibrosis, and transplant outcomes.
- To explore the impact of different assay platforms on uDKK3's clinical utility.
Main Methods:
- Comprehensive literature search of PubMed, Embase, CENTRAL, ClinicalTrials.gov, and conference abstracts up to May 2026.
- Risk of bias assessment using QUIPS.
- Meta-analysis of kidney function decline (HR/OR) and fibrosis correlation (Fisher-z), with random-effects models and assay-aware sensitivity analyses.
Main Results:
- Higher uDKK3 levels were consistently associated with kidney function decline or progression (pooled HR/OR composite 1.82).
- A fibrosis-enriched signal was observed in biopsy cohorts (pooled r=0.62), though imprecise.
- Assay-stratified analyses showed positive trends, with overlapping confidence intervals across different platforms.
Conclusions:
- Urinary Dickkopf-3 (uDKK3) is a robust biomarker for kidney function decline and shows a fibrosis-enriched signal.
- uDKK3 can serve as a complementary biomarker for risk stratification in kidney disease, alongside eGFR and albuminuria.
- Further research is needed for assay harmonization, validation, and prospective utility testing.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Serum Studies: Renal Function Tests
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Diabetic Nephropathy